Articles

Primary biliary cholangitis: innovation and consistency in the EASL guidelines
UDCA and "large" cholestatic liver diseases
«Dissolution» of gall stones: dreams or reality?
Pathogenetic reasons for use of hepatoprotector with approval clinical efficancy - ursodeoxycholic ACID: from discovery history to evidence base
Antibiotic therapy in the time of multidrug resistance: a great future for fosfomycin
ULSEPAN: pantoprazol 40 mg
The use of pantoprazole in the prevention of NSAID gastropathy
Cosmetic or medical problem? Or what should you know about onychomycosis?
Medical solution to a cosmetic issue, or New opportunities in the treatment of nail mycosis
Fungal diseases: an annoying obstacle or medical problem?

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design